Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121713) titled 'Reassessing Statin Intolerance in China: Clinical Reality or Policy Artifact?' on April 1.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Beijing Friendship Hospital ,Capital Medical University
Condition:
Hyperlipidaemia, hypercholesterolaemia, hypertriglyceridaemia, statin intolerance
Intervention:
The no adverse reaction group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: The no adverse reaction group:181;The adverse reaction group:308;
Countries of Recruitment:
China
To know more, visit https://www....